Not Rated
Fund Size
(1.74% of Investment in Category)
|
Expense Ratio
(2.12% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 29-Aug-25 | 10106.10 | 1.06% | - | 1.66% | 184/238 |
1 Month | 05-Aug-25 | 9998.20 | -0.02% | - | 0.88% | 147/242 |
3 Month | 05-Jun-25 | 10096.40 | 0.96% | - | 1.45% | 120/234 |
6 Month | 05-Mar-25 | 11060.30 | 10.60% | - | 13.86% | 180/230 |
YTD | 01-Jan-25 | 9699.00 | -3.01% | - | 1.12% | 157/220 |
1 Year | 05-Sep-24 | 9837.10 | -1.63% | -1.63% | -2.92% | 77/197 |
2 Year | 05-Sep-23 | 14765.70 | 47.66% | 21.48% | 17.87% | 37/153 |
3 Year | 05-Sep-22 | 18673.10 | 86.73% | 23.12% | 18.18% | 25/132 |
5 Year | 04-Sep-20 | 23867.70 | 138.68% | 18.98% | 22.07% | 78/109 |
10 Year | 04-Sep-15 | 35005.70 | 250.06% | 13.33% | 14.33% | 56/83 |
Since Inception | 05-Jun-04 | 513439.50 | 5034.39% | 20.35% | 11.79% | 29/217 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 05-Sep-24 | 12000 | 12255.18 | 2.13 % | 3.95 % |
2 Year | 05-Sep-23 | 24000 | 27441.34 | 14.34 % | 13.43 % |
3 Year | 05-Sep-22 | 36000 | 48743.33 | 35.4 % | 20.66 % |
5 Year | 04-Sep-20 | 60000 | 93977.3 | 56.63 % | 17.97 % |
10 Year | 04-Sep-15 | 120000 | 307217.24 | 156.01 % | 17.87 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 10677.7 | 12.22% | -0.01% | 14.41% (Sep 2024) | 12.22% (Jul 2025) | 62.56 L | 0.00 |
Divis Laboratories Ltd. | Pharmaceuticals | 6595.7 | 7.55% | -0.95% | 9.65% (Nov 2024) | 7.55% (Jul 2025) | 10.00 L | -0.70 L |
Lupin Ltd. | Pharmaceuticals | 5177.7 | 5.93% | -0.14% | 8.47% (Dec 2024) | 5.82% (May 2025) | 26.84 L | 0.00 |
Cipla Ltd. | Pharmaceuticals | 4974.7 | 5.69% | 0.07% | 6.01% (Apr 2025) | 5.32% (Dec 2024) | 32.00 L | 0.00 |
Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 4974.6 | 5.69% | 0.51% | 5.7% (Dec 2024) | 5.1% (Nov 2024) | 39.16 L | 4.54 L |
Apollo Hospitals Enterprises Ltd. | Hospital | 4864.7 | 5.57% | 0.09% | 5.57% (Jul 2025) | 5.13% (Nov 2024) | 6.49 L | 0.00 |
Medplus Health Services Ltd. | Pharmacy retail | 3375.4 | 3.86% | 0.03% | 4.2% (May 2025) | 2.35% (Sep 2024) | 36.27 L | 0.00 |
Vijaya Diagnostic Centre Ltd. | Healthcare service provider | 3103.3 | 3.55% | 0.23% | 4.09% (Nov 2024) | 3.19% (Aug 2024) | 28.87 L | 0.00 |
GlaxoSmithKline Pharmaceuticals Ltd. | Pharmaceuticals | 2888.2 | 3.31% | -0.32% | 3.73% (May 2025) | 2.02% (Jan 2025) | 9.13 L | -5.94 k |
Gland Pharma Ltd. | Pharmaceuticals | 2726.7 | 3.12% | -0.15% | 3.27% (Jun 2025) | 2.59% (Apr 2025) | 13.21 L | -2.09 L |
Name | Type of Instrument | Weight (%) |
---|---|---|
Net Receivables | Net Receivables | 0.29% |
TREPS | TREPS | 0.26% |
Margin | Margin | 0.00% |
Ratios calculated on daily returns for last 3 years (Updated as on 29th August, 2025)
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 351.43 | 16.03 | 35.07 | 40.96 | 52.63 | 30.71 |
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 229.26 | 3.07 | 9.30 | 14.11 | 25.46 | 16.77 |
Motilal Oswal Business Cycle Fund - Regular Plan - Growth | NA | 1949.73 | 1.99 | 4.84 | 14.44 | 18.91 | 0.00 |
Nippon India US Equity Opportunities Fund - Growth | NA | 705.95 | 3.35 | 6.55 | 4.91 | 17.07 | 18.63 |
Nippon India Japan Equity Fund - Growth | NA | 273.12 | 4.46 | 8.26 | 13.42 | 15.38 | 16.71 |
Franklin Asian Equity Fund - Growth | NA | 270.18 | 1.30 | 6.60 | 11.55 | 14.14 | 9.48 |
DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1346.44 | -0.18 | -0.81 | 13.29 | 11.30 | 0.00 |
SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 8450.07 | -0.59 | 1.26 | 16.04 | 9.37 | 17.45 |
Motilal Oswal Manufacturing Fund - Regular Plan - Growth | NA | 774.69 | 2.18 | 1.18 | 22.01 | 9.32 | 0.00 |
HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1450.98 | 8.79 | 17.40 | 33.29 | 8.92 | 0.00 |
Out of 127 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 9 is/are ranked 4 * , 14 is/are ranked 3 * , 7 is/are ranked 2 * , 3 is/are ranked 1 * , and 92 schemes are not ranked. See more about AMC
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Nippon India Small Cap Fund - Growth | 4 | 65922.00 | -0.24 | -0.08 | 17.04 | -7.33 | 22.62 |
Nippon India ETF Nifty 50 BeES | 4 | 48923.13 | 0.53 | 0.50 | 11.69 | -0.41 | 13.11 |
Nippon India ETF Nifty 50 BeES | 4 | 48923.13 | 0.53 | 0.50 | 11.69 | -0.41 | 13.11 |
Nippon India Multicap Fund - Growth | 4 | 45881.41 | 0.78 | 0.96 | 17.01 | -0.33 | 22.51 |
Nippon India Large Cap Fund - Growth | 5 | 44164.76 | 1.37 | 1.68 | 14.57 | 1.32 | 18.92 |
Nippon India Growth Mid Cap Fund - Growth | 4 | 38581.28 | 0.57 | 0.21 | 16.86 | -1.09 | 23.79 |
Nippon India Liquid Fund - Growth | 2 | 35387.59 | 0.46 | 1.45 | 3.30 | 6.89 | 6.95 |
Nippon India Liquid Fund - Growth | 2 | 35387.59 | 0.46 | 1.45 | 3.30 | 6.89 | 6.95 |
CPSE ETF | NA | 33242.49 | -0.85 | -3.27 | 11.66 | -10.21 | 34.20 |
CPSE ETF | NA | 33242.49 | -0.85 | -3.25 | 11.72 | -10.17 | 34.51 |